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VETERINARY MICROBIOLOGY
Prevalence and Characterization of Cephalosporin
Resistance in Nonpathogenic Escherichia coli
from Food-Producing Animals Slaughtered in Poland
Dariusz Wasyl,1 Henrik Hasman,2 Lina M. Cavaco,2 and Frank M. Aarestrup2
The prevalence of Escherichia coli with putative extended-spectrum cephalosporin resistance was assessed in
cattle, pigs, broilers, layers, and turkey slaughtered in Poland. The occurrence of random E. coli isolates re-
covered from MacConkey agar plates with non–wild-type minimal inhibitory concentrations for cefotaxime and
ceftazidime reached 0.6% in layers, 2.3% in turkey, and 4.7% in broilers, whereas all cattle and pigs isolates fell
into the wild-type subpopulation. The use of MacConkey agar supplemented with cefotaxime (2 mg/L) in-
creased the recovery of resistant strains up to 33.3% of samples from pigs, 42.3% from layers, 48.0% from turkey,
and 54.5% from broilers. Still, no cephalosporin-resistant E. coli was found in cattle. E-test identified extended-
spectrum beta-lactamase (ESBL) and ampC-type resistance phenotypes in 15 and 33 strains, respectively. Mo-
lecular characterization identified CTX-M-1 gene in 13 ESBL strains, 5 of which possessed also TEM-1b. One
strain harbored SHV-12 gene. CMY-2 was found in all of 20 tested ampC-type cephalosporinase-positive strains
either alone (n¼ 14) or in combination with mutations in ampC promoter region (n¼ 6). CTX-M-1 and CMY-2
genes were noted also in five strains from laying hens and broilers originated from Belgium and Germany.
Nosocomial infections in Poland are caused by E. coli carrying other determinants than those found in our study.
Thus, our results indicate that animals colonized with cephalosporin-resistant strains might not be the major
source of human infections in Poland. However, the contribution to community-acquired infections by spread of
resistant clones or resistance genes may not be excluded.
Introduction
C ephalosporin-resistant bacteria are frequently foundin nosocomial and community-acquired infections. The
contribution of food of animal origin and direct human to ani-
mal contact remains unclear, but several studies indicated food
animals, pets, and wildlife as a reservoir of cephalosporin-
resistant bacteria.3,4,9,12,13 Numerous enzymes are associated
with extended-spectrum cephalosporin (ESC) resistance includ-
ing extended-spectrum beta-lactamases (ESBL), metallo-beta-
lactamases (MBL), and ampC-type cephalosporinases and can be
differentiated with phenotypic tests.16
The study aimed at assessing of the prevalence of ESC
resistance and characterization of resistance mechanisms in
Escherichia coli isolated from healthy food-producing animals
slaughtered in Poland.
Materials and Methods
Sampling and bacteriological examinations
Rectal/cloacal swabs (n¼ 880) were randomly collected in
2009 during slaughter from cattle, pigs, broilers, turkey, and
layers (Fig. 1). In routine antimicrobial resistance monitoring
(ARM), the swabs were directly streaked onto McConkey
agar. Additionally, 129 of the samples were simultaneously
screened on MacConkey agar supplemented with cefotaxime
(2 mg/L) as described elsewhere.16 Colonies showing typical
E. coli morphology were confirmed in ONPG and indol tube
tests.
Antimicrobial susceptibility testing
Minimum inhibitory concentrations (MICs) were deter-
mined using customized Sensititer plates (Trek Diagnostic
Systems) and interpreted according epidemiological cutoff
values (http://eucast.org) to split bacterial population into
wild-type (WT) and non–wild-type (NWT) strains. The latter
group was considered to contain a resistance mechanism
against the given antimicrobial, thus showing microbiologi-
cal resistance. Isolates showing NWT MICs to ampicillin
(NWT >8 mg/L), ceftazidime (NWT >0.25 mg/L), and ce-
fotaxime (NWT >0.5 mg/L) were screened with E-tests
(bioMerieux) to confirm possible ESC and differentiate be-
tween ESBL, MBL, and ampC-type phenotypes based on the
synergy observed between, respectively, cefotaxime and
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clavulanic acid, imipenem and EDTA, and cefotetan and
cloxacillin.16
Cephalosporin-resistant strains
A single ESC-resistant strain from each sample was se-
lected for molecular characterization of resistance mecha-
nisms as previously described.7 Fifteen ESBL-suspected
strains were tested by PCR for SHV, TEM, CTX-M-1 group,
CTX-M-2 group, and CTX-M-9 group genes. Twenty of 33
isolates showing ampC phenotype were screened for CMY-1
and CMY-2 genes and the ampC promoter was amplified in
14 of these. Sequencing of PCR amplicons was done at
Macrogen Corporation and Vector NTI Advance 11 software
was used for sequence analysis.
Results
The prevalence of E. coli with NWT MICs for both ceph-
alosporins tested varied between the isolation sources (Fig.
1). Routine monitoring identified 13 ESC-positive samples:
three ESBL producers were found in turkeys and ampC
phenotype was noted in broilers (n¼ 8) and single turkey
and layers isolates. Another 12 ESBL producers and 23 ampC-
type resistances were noted in selective screening of pigs (4
and 3, respectively), layers (5 and 5), turkeys (2 and 6), and
broilers (1 and 9). Resistance mechanism identification was
in congruence with phenotypic identification (Table 1). CTX-
M-1 beta-lactamase (n¼ 13) and CMY-2 cephalosporinase
(n¼ 20) were most frequently found in some strains accom-
panied with TEM-1b (n¼ 5) and ampC mutations (n¼ 6). A
single SHV-12–producing strain was noted and the genetic
background of resistance was not identified in another single
strain. Interestingly, three CTX-M1 and two CMY-2 pro-
ducers were found in samples from imported animals. None
of the strains was positive for CTX-M-2 group, CTX-M-9
group, or CMY-1.
Discussion
Our study showed that poultry and pigs might be a res-
ervoir of third-generation cephalosporin-resistant E. coli.
Compared with humans mostly colonized with a defined
resistant strain,6,11 enteric bacteria in healthy animals con-
stitute of mixed commensal population including a fraction
of ESC strains.1,8–10 Previous studies have demonstrated that
selective screening is needed for enhanced recovery of such
isolates.3,16 Cephalosporin usage may select for higher
prevalence of strains with NWT MICs and explain the ob-
served differences in different animal reservoirs.3,10,13
Although we cannot distinctly conclude on the real
prevalence of ESC in E. coli, the resistance mechanisms were
identified. Like few other studies, ESBL-positive strains were
less frequent compared with ampC-type cephalosporinase
producers.5,13 In contrast with other studies,5,8,10 no ESC
genes were found in cattle isolates. Surprisingly, a low di-
versity of resistance genes was found, although the strains
were obtained over several months from various animal
species at random, countrywide settings. Recent ESC studies
have revealed a variety of genes present in animal gut flora
and the ones found in our study have been already reported
in wild, food-producing and companion animals, both in
commensal E. coli and clinical cases.1–5,9,10,13 They were often
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FIG. 1. ESC prevalence in Escherichia coli isolated from food
animals (digits in brackets stands for number of samples
tested with screening method). *Because of random sam-
pling, 2 samples were collected from imported broilers (SK),
and 32 laying flocks originated from Belgium (n¼ 5), Czech
Republic (n¼ 4), Germany (n¼ 10), Lithuania (n¼ 1), The
Netherlands (n¼ 4), and Slovak Republic. ESC, extended-
spectrum cephalosporin.
Table 1. Resistance Mechanisms by Source of Escherichia coli Isolation
No. of strains
Phenotype Resistance mechanism Pigs Layers Broilers Turkeys Total
ESBL (n¼ 15) CTX-M-1 2 3a 3 8
CTX-M-1þTEM-1b 1 2 1 1 5
SHV-12 1 1
Not identified 1 1
ampC (n¼ 33) CMY-2 4b 10b 14
CMY-2þampC overexpression:
C-88TþA-82GþG-18AþC-1TþC58T 1 2 1 4
C-73TþG-28AþC58T 2 2
Not tested 2 2 3 6 13
aStrains isolated from flocks imported from Belgium.
bStrain isolated from flocks imported from Germany.
ESBL, extended-spectrum beta-lactamase.
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found in associations1,12 including promoter mutations re-
sulting in hyperproduction of chromosomal ampC beta-
lactamases.3,12
This is the first study on the genetic background of ESC in
commensal E. coli isolated from animals slaughtered in
Poland, although numerous reports are available from other
countries.1–5,7,9,13 Unsurprisingly, two predominant resis-
tance mechanisms were also found in strains traced back to
flocks originating from three other countries.
Animals via contaminated food or direct contact might
contribute to human colonization with resistant bacteria. For
example, CTX-M-1 beta-lactamase was previously reported
in beef and poultry meat in Tunisia and chicken breast in the
United Kingdom.8,15 The prevalence of TEM-52 in animals
was correlated to human infections in Portugal.2,3 Because of
plasmidic location of most of ESC resistance genes, numer-
ous studies relate animal-to-man spread of ESC rather to
plasmid transfer than clonal spread of bacteria.1,3,4,9–11
Having the above in mind as well as a variety of genes found
in healthy humans,10,14 one may assume that transmission of
ESC might occur within the food chain. This scenario may
not be confirmed by our findings, supported with public
health data on high prevalence of CTX-M-15 and M-3 nos-
ocomial infections.6 Similar discrepancies between ESC re-
sistance genes found in man and food have been reported by
Warren et al.15
Our report adds new country to the worldwide landscape
of ESC occurrence in indicator E. coli isolated from animals.
The findings do not support food animals colonized with
resistant strains as a major source of human infections, al-
though they might contribute to international spread of re-
sistance mechanisms and compromise animal welfare. At
some point it might also challenge human health precisely
with respect to community-acquired infections with ESC
bacteria. This issue could be verified by simultaneous survey
of animals, foods, and nondiseased individuals representa-
tive of the community.
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